Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.075 USD | +1.82% | -8.43% | -65.42% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-65.42% | 315M | |
-3.05% | 90.45B | |
+3.68% | 41.45B | |
-11.00% | 33.57B | |
+60.01% | 25.73B | |
-20.26% | 14.73B | |
-8.89% | 12.82B | |
-11.34% | 11.7B | |
-43.53% | 11.44B | |
+5.02% | 8.79B |
- Stock Market
- Equities
- RVNC Stock
- News Revance Therapeutics, Inc.
- Morgan Stanley Lowers Price Target on Revance Therapeutics to $12 From $25, Maintains Equalweight Rating